Real-world study of heart muscle thickening disease
Part of Heart & circulation clinical trials.
This study follows patients with HCM (a condition where the heart muscle becomes abnormally thick) to understand how the disease affects them over time in everyday life. The goal is to learn more about treatment outcomes and quality of life for people living with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with HCM (heart muscle wall thickness of 15mm or more, or 13mm with family history or genetic testing)
- Willing to sign consent form and commit to follow-up visits
- No other conditions causing similar heart thickening (like amyloidosis, Fabry disease, or sarcoidosis)
- No severe high blood pressure or severe aortic valve disease
- No active cancer or other serious illnesses expected to shorten lifespan below 3 years
- No serious mental health conditions that would prevent study participation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how hypertrophic cardiomyopathy (HCM) affects people in China in real-world settings. It may help doctors understand the condition better and improve care for patients like you.
This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.
This study is a registry that collects information about people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) to better understand how it affects different people and to study its genetic causes. By joining, you help researchers learn more about this condition and how it progresses.
This trial tests a new drug, Aom0304, for people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) who still have symptoms despite standard treatments. The study aims to see if the drug can improve symptoms and heart function.
This study uses MRI scans to re-examine people with hypertrophic cardiomyopathy (a thickening of the heart muscle) who were part of the original HCMR study. It compares different types of HCM to learn more over time.
This study looks at people who have been newly diagnosed with heart failure to find rare forms of heart muscle disease (cardiomyopathy) early and start the right treatment. It uses advanced heart imaging (CMR) and requires that you have not had heart problems before.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.